First Hawaiian Bank’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

First Hawaiian Bank’s Portfolio HZNP Stock Details HZNP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-4,273	Closed	-$466K	–	919
2023 Q1	$466K	Sell	4,273 -14,050	-77%	-$1.55M	0.02%	608
2022 Q4	$2.08M	Hold	18,323	–	–	0.08%	194
2022 Q3	$1.13M	Sell	18,323 -28,570	-61%	-$2M	0.04%	301
2022 Q2	$3.74M	Buy	46,893 +2,021	+5%	+$191K	0.14%	90
2022 Q1	$4.72M	Buy	44,872 +649	+1%	+$63.2K	0.15%	84
2021 Q4	$4.76M	Buy	44,223 +10,824	+32%	+$1.18M	0.14%	94
2021 Q3	$3.66M	Buy	33,399 +14,482	+77%	+$1.5M	0.15%	83
2021 Q2	$1.77M	Buy	18,917 +6,200	+49%	+$571K	0.07%	174
2021 Q1	$1.17M	Sell	12,717 -266	-2%	-$22.4K	0.05%	265
2020 Q4	$950K	Sell	12,983 -2,402	-16%	-$179K	0.04%	290
2020 Q3	$1.2M	Buy	15,385 +2,185	+17%	+$150K	0.06%	217
2020 Q2	$734K	Sell	13,200 -3,570	-21%	-$153K	0.04%	323
2020 Q1	$497K	Hold	16,770	–	–	0.03%	379
2019 Q4	$607K	Hold	16,770	–	–	0.03%	403
2019 Q3	$457K	Buy	+16,770	New	+$434K	0.02%	488
2019 Q2	–	Sell	-17,970	Closed	-$475K	–	1702
2019 Q1	$475K	Hold	17,970	–	–	0.03%	456
2018 Q4	$351K	Hold	17,970	–	–	0.02%	526
2018 Q3	$352K	Buy	+17,970	New	+$342K	0.02%	580

Other funds holding HZNP

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

PCM

Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

First Hawaiian Bank's HZNP Position: Q2 2023 in Review

First Hawaiian Bank sold out of Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q2 2023, closing a stake of 4,273 shares — an estimated $466K sold.

First Hawaiian Bank first reported a position in HZNP in Q3 2018 and held it in 18 quarters. The position peaked at $4.76M in Q4 2021. 519 funds tracked by Wall St. Rank hold HZNP as of Q2 2023.

First Hawaiian Bank reported no remaining Horizon Therapeutics Public Limited Company Ordinary Shares position as of Q2 2023 after selling out during the quarter.
First Hawaiian Bank sold 4,273 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q2 2023, an estimated $466K.
First Hawaiian Bank first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q3 2018 and held it in 18 quarters.
First Hawaiian Bank's Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $4.76M in Q4 2021.
519 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q2 2023.

Based on First Hawaiian Bank's 13F filing for Q2 2023, filed 7 Jul 2023.